Etiology and antibiotic resistance patterns of Community-Acquired extended-spectrum Beta-Lactamase-producing gram negative Isolates in Sanandaj

Research Journal of Medical Sciences

Volumn 4, Issue 3, 2010, Pages 243-247

  Ramazanzadeh, Ashid ^a   Farhadifar, Fariba ^a   Mansouri, Majid ^a  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibiotic; Bacterial stain; Community acquired; Extended spectrum beta lactamase; Infaction; Pathogen

Indexed keywords

AMIKACIN; AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; TETRACYCLINE;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD CULTURE; CITROBACTER FREUNDII; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; DISK DIFFUSION; ENTEROBACTER; ESCHERICHIA COLI; GENE IDENTIFICATION; HUMAN; IRAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; OUTPATIENT; POLYMERASE CHAIN REACTION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ARIZONAE; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 78649749768     PISSN: 18159346     EISSN: 19936095     Source Type: Journal    
DOI: 10.3923/rjmsci.2010.243.247     Document Type: Article

References (19)

1. Apisarnthanarak, A., P. Kiratisin, and L.M. Mundy, 2008. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect. Control Hospital Epidemiol., 29: 671-674.
2. Apisarnthanarak, A., P. Kiratisin, P. Saifon, R. Kitphati, S. Dejsirilert, and L.M. Mundy, 2007. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: A case-case-control study. Am. J. Infect. Control, 35: 606-612.
3. Bradford, P.A., 2001. Extended-spectrum beta-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin. Microbiol. Rev., 14: 933-951.
4. Hosseini-Mazinani, S.M., F. Eftekhar, M. Milani and S. Ghandili, 2007. Characterization of beta-lactamases from urinary isolates of Escherichia coli in Tehran. IranBiomed. J., 11: 95-99.
5. Jacoby, G.A. and L. Sutton, 1991. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob. Agents Chemother., 35: 164-169.
6. Jarlier, V., M.H. Nicolas, G. Fournier and A. Philippon, 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev. Infect. Dis., 10: 867-878.
7. Laupland, K.B., D.L. Church, J. Vidakovich, M. Mucenski and J.D. Pitout, 2008. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia colt Importance of international travel. J. Infect, 57: 441-448.
8. Lin, T.L., S.I. Tang, C.T. Fang, P.R. Hsueh, S.C. Chang and J.T. Wang, 2006. Extended-spectrum beta-lactamase genes of Klebsiella pneumoniae strains in Taiwan: Recharacterization of shv-27, shv-41 and tem-116. Microbial Drug Resistance, 12: 12-15.
9. Mehrgan, H. and M. Rahbar, 2008. Prevalence of extended-spectrum beta-lactam as e-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int. J. Antimicrob. Agents, 31: 147-151.
10. Mendelson, G., V. Hait, J. Ben-Israel, D. Gronich, E. Granot, and R. Raz, 2005. Prevalence and risk factors of extended-spectrum beta-lactam as e-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur. J. Clin. Microbiol. Infect Dis., 24: 17-22.
11. NCCLS Document M2-A7, 2000. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard. 7th Edn., National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Paterson, D.L., 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control, 34: S20-S28.
13. Rodriguez-Bano, J., M.D. Navarro, L. Romero, M.A. Muniain and M.D. Cueto et al., 2006. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in the CTX-M era: A new clinical challenge. Clin. Infect. Dis., 43: 1407-1414.
14. Rodriguez-Bano, J., M.D. Navarro, L. Romero, L. Martinez-Martinez and M.A. Muniain et al, 2004. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamas e-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol., 42: 1089-1094.
15. Shahcheraghi, F., H. Moezi, and M.M. Feizabadi, 2007. Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med. Sci. Monit, 13: BR247-BR250.
16. Sidorenko, S.V., A.G. Berezin, and D.V. Ivanov, 2004. [Molecular mechanisms of cephalosporin resistance in Gram-negative bacteria of the Enterobacteriaceae family]. Antibiot Khimioter, 49: 6-16.
17. Valverde, A., T.M. Coque, M.P. Sanchez-Moreno, A. Rollan, F. Baquero, and R. Canton, 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lac tamas e-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol., 42: 4769-4775.
18. Woodford, N, M.E. Ward, M.E. Kaufmann, J. Turton and E.J. Faqan et al., 2004. Community and hospital spread of Escherichia coli producing CTX-M extended spectrum beta-lactamases in the UK. J. Antimicrob. Chemother., 54: 735-743.
19. Yao, F., Y. Qian, S. Chen, P. Wang and Y. Huang, 2007. Incidence of extended-spectrum beta-lactamases and characterization of integrons in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated in Shantou, China. Acta. Biochim. Biophys. Sin (Shanghai), 39: 527-532.